Skip to page navigation menu Skip entire header
Brown University
Skip 13 subheader links

Six-month oral medication adherence early in disease course as a predictor of pediatric inflammatory bowel disease-specific outcomes over time

Description

Abstract:
There are a variety of medications used to control the symptoms of inflammatory bowel disease (IBD). Adherence early in disease course to two commonly prescribed medications, mercaptopurine (6-MP) and mesalamine (5-ASA), may be associated with fewer disease complications over time. We examined the relationship of adherence to 6-MP and 5-ASA during the first six months after IBD diagnosis with measures of disease complication including hospital encounters, surgical resections, and corticosteroid use in children and adolescents over a median 6.4 years of follow-up.
Notes:
Thesis (Sc. M.)--Brown University, 2017
Concentration: Biostatistics

Access Conditions

Rights
In Copyright
Restrictions on Use
Collection is open for research.

Citation

Millenson, Marisa E., "Six-month oral medication adherence early in disease course as a predictor of pediatric inflammatory bowel disease-specific outcomes over time" (2017). Biostatistics Theses and Dissertations. Brown Digital Repository. Brown University Library. https://doi.org/10.7301/Z0T1523X

Relations

Collection: